Tarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.
Aziz Mottiwala
Advertisement
Articles by Aziz Mottiwala
Aziz Mottiwala, the Chief Commercial Officer at Tarsus Pharmaceuticals, shares a pipeline update.
Advertisement
Latest Updated Articles
AAOpt 2022: What's in the pipeline for TarsusNovember 7th 2022
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Exercise for the prevention and mitigation of eye disease
2
Georgia university receives state funding for state's first college of optometry
3
Bausch + Lomb launches preservative-free version of Blink Triple Care eye drops
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5